Richard Close
Stock Analyst at Canaccord Genuity
(1.99)
# 2,899
Out of 4,711 analysts
126
Total ratings
38%
Success rate
-9.58%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintains: Hold | $18 → $17 | $14.34 | +18.55% | 5 | Nov 13, 2024 | |
| DOCS Doximity | Downgrades: Hold | $40 → $60 | $57.83 | +3.75% | 8 | Nov 13, 2024 | |
| WAY Waystar Holding | Maintains: Buy | $30 → $36 | $36.82 | -2.23% | 2 | Nov 7, 2024 | |
| PINC Premier | Maintains: Hold | $19 → $21 | $21.76 | -3.49% | 11 | Nov 6, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $14 → $13 | $10.28 | +26.46% | 6 | Nov 6, 2024 | |
| HSTM HealthStream | Maintains: Hold | $28 → $29 | $31.45 | -7.79% | 5 | Oct 23, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $7 | $3.48 | +101.15% | 8 | Oct 9, 2024 | |
| PHR Phreesia | Maintains: Buy | $34 | $25.16 | +35.14% | 8 | Sep 5, 2024 | |
| QIPT Quipt Home Medical | Maintains: Buy | $8 → $6 | $2.49 | +140.96% | 3 | Aug 16, 2024 | |
| TDOC Teladoc Health | Maintains: Buy | $25 → $17 | $9.44 | +80.08% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $122.99 | -1.62% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $7.09 | +55.15% | 6 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $26 | $20.07 | +29.55% | 7 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $41 | $11.41 | +259.33% | 10 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $4.51 | +10.86% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $3.23 | -7.12% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.44 | +15,525.00% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $22.91 | +4.76% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $72.94 | +30.24% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $42.83 | -58.56% | 4 | Dec 20, 2018 |
Progyny
Nov 13, 2024
Maintains: Hold
Price Target: $18 → $17
Current: $14.34
Upside: +18.55%
Doximity
Nov 13, 2024
Downgrades: Hold
Price Target: $40 → $60
Current: $57.83
Upside: +3.75%
Waystar Holding
Nov 7, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $36.82
Upside: -2.23%
Premier
Nov 6, 2024
Maintains: Hold
Price Target: $19 → $21
Current: $21.76
Upside: -3.49%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $14 → $13
Current: $10.28
Upside: +26.46%
HealthStream
Oct 23, 2024
Maintains: Hold
Price Target: $28 → $29
Current: $31.45
Upside: -7.79%
Accolade
Oct 9, 2024
Maintains: Buy
Price Target: $13 → $7
Current: $3.48
Upside: +101.15%
Phreesia
Sep 5, 2024
Maintains: Buy
Price Target: $34
Current: $25.16
Upside: +35.14%
Quipt Home Medical
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.49
Upside: +140.96%
Teladoc Health
Aug 1, 2024
Maintains: Buy
Price Target: $25 → $17
Current: $9.44
Upside: +80.08%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $122.99
Upside: -1.62%
May 21, 2024
Maintains: Buy
Price Target: $11
Current: $7.09
Upside: +55.15%
May 10, 2024
Maintains: Buy
Price Target: $37 → $26
Current: $20.07
Upside: +29.55%
May 10, 2024
Maintains: Buy
Price Target: $44 → $41
Current: $11.41
Upside: +259.33%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $4.51
Upside: +10.86%
Mar 6, 2023
Maintains: Buy
Price Target: $4 → $3
Current: $3.23
Upside: -7.12%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.44
Upside: +15,525.00%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $22.91
Upside: +4.76%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $72.94
Upside: +30.24%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $42.83
Upside: -58.56%